Back

New and emerging therapies for HFpEF

18 May 2025 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation? Treatment HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Ms Kamile Cerlinskaite-Bajore

Vilnius University, Vilnius (Lithuania)

3 More presentations in this session

Presentation thumbnail
Broadening the scope: should we implement guideline-directed medical therapy across all left ventricular ejection fraction ranges?
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
How to approach a patient with HFimpEF
Professor W. Mullens (Genk, BE)
Slides Video
Presentation thumbnail
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation? - discussion
Video

Access the full session

Session thumbnail
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 14:00 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on treatment of HFpEF
thumbnail
Congress Presentation
Advances in the treatment of HFpEF
thumbnail
Congress Session
The challenging world of heart failure with preserved ejection fraction (HFpEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources